Krsnaa Diagnostics Clarifies Preferential Warrant Premium Pricing
Krsnaa Diagnostics Ltd · Others (Uncategorized) · 14 Oct 2026, 7:36 pm
Krsnaa Diagnostics Clarifies Preferential Warrant Premium Pricing Krsnaa Diagnostics issued a clarification regarding its 13th Oct'26 intimation on the allotment of fully convertible warrants on a preferential basis. The company corrected a typographical error concerning the issue premium, stating that the premium per warrant is ₹561 instead of the previously reported ₹551 per warrant. All other terms and details from the original intimation remain unchanged.
Original exchange filing (PDF)
More announcements from Krsnaa Diagnostics Ltd
- Earnings Call Transcript for quarter and half year ended September 30, 2026 · 08 Nov 2026
- Intimation of Change in Corporate office of Registrar and Sahre Trasnfer Agent of the Company w.e.f. 1st December 2026. · 04 Nov 2026
- Audio recording of conference call for the quarter and half year ended September 30, 2026 · 04 Nov 2026
- Submission of Certificate obtained from Statutory Auditors in terms of Regulation 169(5) of the SEBI ICDR Regulations, 2018 · 03 Nov 2026
- Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 - Krsnaa Diagnostics secures 15 year Cash based PPP project from Municipal corporation of Delhi for Advanced CT Scan and .... · 03 Nov 2026
- Investor Presentation for the Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half year ended September 30, 2026 · 03 Nov 2026
- Press Release - Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half year ended September 30, 2026 · 03 Nov 2026
- Financial Results for Quarter and Half Year ended September 30, 2026 · 02 Nov 2026
